OneKind AI was selected as an honouree in BetaKit's Most Ambitious 2026 — an annual editorial project recognising nearly 100 Canadian companies shaping Canada's technology landscape.
We were recognised under Canada's Food Chain. Animal health is where we work — but the infrastructure we're building extends further. ORIGIN, our platform for AI-originated clinical endpoints, is designed around evidence integrity: traceable data, reproducible results, and audit-ready workflows for regulated pharma studies. That means data sovereignty isn't an afterthought — it's a design principle.
Being included among Canada's most ambitious builders reflects both the problem worth solving and the team committed to solving it.